BioSapien extends pre-Series A to $8 million, onboards Globivest as investor
Founded in 2018 by Khatija Ali, BioSapien offers a flagship product, MediChip™, which is a drug delivery, 3D-printed, slow-release delivery platform attachable to any tissue with minimal systemic side effects.
The funding will support product development and global expansion, with 12 new executives hired across R&D, medical affairs, regulatory, and operations. Key appointments include Joseph Borrello as CTO and Sonia Ramamoorthy as Head of Medical Affairs.
Press release:
BioSapien, the pioneering biotech company behind MediChip™, a revolutionary localised cancer treatment platform, announces a new extension to its pre-Series A funding round and the appointment of new talent across the business, including Joseph Borrello, PhD, as Chief Technology Officer; Sonia Ramamoorthy MD MBA FACS as Head of Medical Affairs; Agnes Westelinck, PharmD, as Head of Regulatory U.S.; Dirk Richter MD FACS as Head of Regulatory U.A.E.; David Briere, PhD, as Director of Pharmacology; and Jerry Webb, BSc, as Head of Quality.
BioSapien is delighted to welcome Globivest as an investor in the pre-Series A funding round. Globivest is the first women-led, gender lens venture capital fund from the MENA region and has expertise in Life Sciences.
BioSapien's pre-Series A funding total is now over $8 million, with investors including Global Ventures – a leading VC firm in MENA; plus Golden Gate Ventures and Dara Holdings.
Globivest's stated mission is to break the myth that opposes capital returns to impact-driven models. Championing the WHO's 'One Health' approach, it specialises in innovative and scalable early-stage startups that drive health, social, and environmental change – making BioSapien an ideal fit for its portfolio.
BioSapien also announces the acquisition of world-class talent across all tiers of the company— with 12 new appointments. In addition to the appointments listed above, other new talent includes Zhiyu Xia PhD as Senior Manufacturing Engineer, Gaurav Vij MBA as Business Officer; Nancy Sperling MS MS as the QC Lead, Nivedita Sivakumar PharmD MS as Documentation and Compliance Manager, Manny Valenza BA as Clinical Development Associate and Jared Rice BA as the Research and Operations Lead.
Dr. Khatija Ali, CEO of BioSapien, said:
'Two of the greatest challenges for young, fast-growing companies are establishing a strong balance sheet and attracting high-quality talent. Therefore, I am delighted to announce an extension of BioSapien's pre-Series A funding round. As a female-led healthcare fund in the MENA region - and backed by EU pharma - we are proud to have Globivest as an investor and strategic partner.
'Similarly, it gives me great pleasure to welcome new, world-class colleagues across all tiers of the Company. A business is only as good as its people - so it is thrilling to be joined by such high-quality, diverse talent. Together, we will shape a future where precision medicine is both globally impactful and locally accessible.'
Dr. Laura-Joy Boulos, Partner at Globivest, commented:
'At Globivest, we back companies that don't just promise innovation – they deliver transformative, science-backed solutions with the power to shift paradigms. BioSapien's MediChip™ platform is a breakthrough in localised cancer treatment – scalable, precise, and deeply aligned with our One Health mission. We're proud to support Dr. Khatija Ali and her team as they build the future of accessible precision medicine.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wamda
10 hours ago
- Wamda
BioSapien extends pre-Series A to $8 million, onboards Globivest as investor
UAE and US-based healthtech BioSapien has extended its pre-Series A round to over $8 million, adding Globivest to its list of backers, alongside Global Ventures, Golden Gate Ventures, and Dara Holdings. Founded in 2018 by Khatija Ali, BioSapien offers a flagship product, MediChip™, which is a drug delivery, 3D-printed, slow-release delivery platform attachable to any tissue with minimal systemic side effects. The funding will support product development and global expansion, with 12 new executives hired across R&D, medical affairs, regulatory, and operations. Key appointments include Joseph Borrello as CTO and Sonia Ramamoorthy as Head of Medical Affairs. Press release: BioSapien, the pioneering biotech company behind MediChip™, a revolutionary localised cancer treatment platform, announces a new extension to its pre-Series A funding round and the appointment of new talent across the business, including Joseph Borrello, PhD, as Chief Technology Officer; Sonia Ramamoorthy MD MBA FACS as Head of Medical Affairs; Agnes Westelinck, PharmD, as Head of Regulatory U.S.; Dirk Richter MD FACS as Head of Regulatory U.A.E.; David Briere, PhD, as Director of Pharmacology; and Jerry Webb, BSc, as Head of Quality. BioSapien is delighted to welcome Globivest as an investor in the pre-Series A funding round. Globivest is the first women-led, gender lens venture capital fund from the MENA region and has expertise in Life Sciences. BioSapien's pre-Series A funding total is now over $8 million, with investors including Global Ventures – a leading VC firm in MENA; plus Golden Gate Ventures and Dara Holdings. Globivest's stated mission is to break the myth that opposes capital returns to impact-driven models. Championing the WHO's 'One Health' approach, it specialises in innovative and scalable early-stage startups that drive health, social, and environmental change – making BioSapien an ideal fit for its portfolio. BioSapien also announces the acquisition of world-class talent across all tiers of the company— with 12 new appointments. In addition to the appointments listed above, other new talent includes Zhiyu Xia PhD as Senior Manufacturing Engineer, Gaurav Vij MBA as Business Officer; Nancy Sperling MS MS as the QC Lead, Nivedita Sivakumar PharmD MS as Documentation and Compliance Manager, Manny Valenza BA as Clinical Development Associate and Jared Rice BA as the Research and Operations Lead. Dr. Khatija Ali, CEO of BioSapien, said: 'Two of the greatest challenges for young, fast-growing companies are establishing a strong balance sheet and attracting high-quality talent. Therefore, I am delighted to announce an extension of BioSapien's pre-Series A funding round. As a female-led healthcare fund in the MENA region - and backed by EU pharma - we are proud to have Globivest as an investor and strategic partner. 'Similarly, it gives me great pleasure to welcome new, world-class colleagues across all tiers of the Company. A business is only as good as its people - so it is thrilling to be joined by such high-quality, diverse talent. Together, we will shape a future where precision medicine is both globally impactful and locally accessible.' Dr. Laura-Joy Boulos, Partner at Globivest, commented: 'At Globivest, we back companies that don't just promise innovation – they deliver transformative, science-backed solutions with the power to shift paradigms. BioSapien's MediChip™ platform is a breakthrough in localised cancer treatment – scalable, precise, and deeply aligned with our One Health mission. We're proud to support Dr. Khatija Ali and her team as they build the future of accessible precision medicine.'
Wamda
12 hours ago
- Wamda
TruKKer raises $15 million debt from Ruya Partners
Saudi Arabia-based digital freight network TruKKer has secured a $15 million private credit investment from Ruya Partners, through its flagship Ruya Private Capital I fund. Founded in 2016, TruKKer operates across 9 countries and connects 60,000+ transporters with 1,200+ enterprise clients through a real-time, AI-enabled freight marketplace. The funding will support regional expansion, tech enhancements, and further consolidation of its freight-tech leadership. In 2022, TruKKer raised $100 million in a pre-IPO round, led by Bahraini investment firm Investcorp. Press release: Ruya Partners, a leading private credit investment firm in the GCC, is pleased to announce the closing of a $15 million (SAR 55 million) private credit investment in TruKKer Holding Limited, the largest digital freight and logistics platform across the Middle East, North Africa, and Central Asia. The transaction marks the sixth investment from Ruya Private Capital I, the firm's flagship private credit fund. This financing will enable TruKKer to deepen its regional expansion, enhance technology capabilities, and further solidify its position as the region's primary freight-tech platform. Backing a Regional Freight-Tech Champion Founded in 2016, TruKKer operates a real-time, technology-enabled freight marketplace that connects over 60,000 transporters with more than 1,200 enterprise clients across 9 countries. Its platform streamlines and digitises road freight operations, offering intelligent dispatching, scheduling, and capacity optimisation at scale. TruKKer has developed proprietary tech solutions that enable thousands of truck owners and managers to connect with the region's leading manufacturers, traders, and contractors along with multiple stakeholders with complex documentation seamlessly through one network solution. 'TruKKer is a standout example of entrepreneurial innovation reshaping the logistics sector across our region,' said Rashid Siddiqi, Partner and Co-CIO at Ruya Partners. 'The company has pioneered the digital transformation of freight in a traditionally fragmented industry, driving greater efficiency, transparency, and connectivity across regional supply chains. Our investment reflects Ruya's commitment to backing high-quality businesses with long-term relevance, particularly those like TruKKer that align with national transformation priorities of Saudi Arabia and the UAE. Partnering for Long-Term Growth 'We are pleased to welcome Ruya Partners as a long-term strategic investor,' said Gaurav Biswas, Founder and CEO of TruKKer. 'Their participation adds depth to our institutional investor base and reflects continued confidence in the strength of our business fundamentals and financial profile. As we expand our footprint and product offering, this investment enhances our capital structure and supports our broader mission to digitise and optimise freight and supply chain operations across multiple logistics verticals. We are on a mission to solve the complex & simple challenges of this megasector of logistics in the most rapidly transforming region of the world. "TruKKer represents the type of high-impact, technology-driven business we seek to partner with, one that is transforming traditional industries and driving regional integration. As the sixth investment from our flagship fund and our fifth financing supporting Saudi growth, this commitment reaffirms our conviction in the Kingdom's freight-tech evolution. With this investment, Ruya Private Capital Fund I is now 90% invested, demonstrating strong deployment momentum into resilient, future-forward businesses that align with national transformation agendas." Added Omar AlYawer, Partner & Chief Capital Formation Officer at Ruya Partners.
Al Bawaba
12 hours ago
- Al Bawaba
Dubai and India strengthen their strategic partnership in trade and logistics services
As part of its ongoing efforts to develop international economic relations and facilitate trade between Dubai and its trading partners, Dubai Customs hosted an expanded meeting with the participation of a delegation from the Republic of India, headed by Arti Agarwal Srinivas Director General, Directorate General of Systems and Data Management at the Central Board of Indirect Taxes and Customs (CBIC).A delegation from DP World also participated in the meeting. The meeting tackled ways to enhance cooperation in inter-MENA trading trends and supply chain, logistics services, fast-tracked clearance procedures, and customs facilitations used to accelerate trade movement and increase the flow of goods. The meeting also discussed the development of the India-Middle East-Europe Economic Corridor (IMEEC) and its associated virtual trade corridor. At the beginning of the meeting, His Excellency Dr. Abdulla Busenad, Director General of Dubai Customs, welcomed the visiting delegation, emphasizing that this visit is part of the Dubai Economic Agenda's vision to enhance Dubai's role as a global trade and logistics also underscores the strength of relations between Dubai and India, which are witnessing rapid growth across various economic sectors. Moreover, we are working to facilitate trade with Dubai's trading partners in Asia, the first one of them is the Republic of India. Our goals are to encourage investment, facilitate trade, and enhance Dubai's position on global competitiveness indicators. For her part, the head of the Indian delegation, Arti Agarwal Srinivas, praised the significant developments witnessed by Dubai's customs and logistics system, emphasizing that India views Dubai as a pivotal partner in supporting the smooth flow of supply chain and a strategic gateway to markets in the Middle East, Africa, and Europe. The meeting was attended by Mansoor Al-Malik, Executive-Director for Policies and Legislation Division at Dubai Customs, and Ateeq Al Muhairi, the Executive Director of the Customs Development Sector at Dubai Customs. 'The MAITRI platform' was reviewed; it is a single digital platform that aims to facilitate the data exchange between Customs and Port systems in the UAE and India. This aims to increase the movement of goods, reduce delays and customs costs, and open up broader horizons for logistics partnerships that serve common interests and keep pace with future ambitions.
